NorthWest Biotherapeutics Inc (NWBO)

[Bacchus1]

From the MHRA website:

5.4 To comply with GMP, holders of a Manufacturer’s Licence (MIA) must:
• establish and implement an effective pharmaceutical quality assurance system;
• have competent and appropriately qualified personnel, sufficient in number to
achieve the pharmaceutical quality objective(s);
• define the duties of managerial and supervisory staff responsible for implementing
and operating GMP in their job descriptions;
• give personnel sufficient authority and training to meet the pharmaceutical quality
objective(s);
• institute and maintain hygiene programmes relating to health, hygiene and clothing;
• provide and maintain premises and equipment appropriate to the intended
operations;
• have system(s) of documentation covering all the processes and specifications
covering the various operations. Batch documentation must be retained at least one
year after the expiry date of the batch to which it relates;
• provide and maintain an independent quality control department, under the authority
of the person nominated as responsible for overall quality control;
• retain records and samples of starting materials and finished products for the
required periods;
• ensure that any work contracted out is the subject of a written contract;
• maintain an effective system whereby complaints are reviewed and products may be
recalled;
• carry out a programme of regular self-inspection.

Seems to suggest that Advent will be the holders of the licence.